pIA123
(Plasmid
#234038)
-
PurposeE. coli-C. difficile shuttle vector for CRISPR editing in C. difficile. Pxyl::Cas9-opt Pgdh::sgRNA-cdr_0985. PstI site to add DNA for homology directed repair. MscI and NotI for replacement of sgRNA.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 234038 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepIA33
- Backbone size w/o insert (bp) 6300
- Total vector size (bp) 12940
-
Vector typeBacterial Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol, 25 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameCas9
-
Alt nameCas9 nuclease, codon optimized for C. difficile
-
SpeciesStreptococcus pyogenes
- Promoter Pxyl
Cloning Information for Gene/Insert 1
- Cloning method Gibson Cloning
- 5′ sequencing primer unknown
- 3′ sequencing primer unknown (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namesgRNA
-
Alt namesingle guide RNA, targeting cdr_0985
-
SpeciesStreptococcus pyogenes
- Promoter Pgdh
Cloning Information for Gene/Insert 2
- Cloning method Gibson Cloning
- 5′ sequencing primer unknown
- 3′ sequencing primer unknown (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pIA123 was a gift from Craig Ellermeier (Addgene plasmid # 234038 ; http://n2t.net/addgene:234038 ; RRID:Addgene_234038) -
For your References section:
Identification of a family of peptidoglycan transpeptidases reveals that Clostridioides difficile requires noncanonical cross-links for viability. Bollinger KW, Muh U, Ocius KL, Apostolos AJ, Pires MM, Helm RF, Popham DL, Weiss DS, Ellermeier CD. Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2408540121. doi: 10.1073/pnas.2408540121. Epub 2024 Aug 16. 10.1073/pnas.2408540121 PubMed 39150786